GNKG168
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GNKG168, covering 2014-12-23 to 2025-01-27. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia [Phase 1]